2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017

BACKGROUND: Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) against pneumococcal pneumonia in adults aged >65 years was shown in a 2014 clinical trial. However, its benefits in countries with a mature PCV infant program remain unclear. In August 2014, PCV13 was recommended for all US...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessa, Fernanda C, Spiller, Michael, Wu, Xiyuan, Wang, Rongrong, Chillarige, Yoganand, Wernecke, Michael, MaCurdy, Thomas E, Kelman, Jeffrey A, Shang, Nong, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809715/
http://dx.doi.org/10.1093/ofid/ofz360.2395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809715/
http://dx.doi.org/10.1093/ofid/ofz360.2395

Ejemplares similares